# 67457-421-30 · Dexamethasone Sodium Phosphate Injection · Mylan Institutional, a Viatris Company — FDA drug shortage duration tracker

For 67457-421-30 · Dexamethasone Sodium Phosphate Injection · Mylan Institutional, a Viatris Company, package ndc is 67457-421-30; generic name is Dexamethasone Sodium Phosphate Injection; manufacturer is Mylan Institutional, a Viatris Company; status is Current; availability now is Available, recorded from its source on 2026-09-01; source re-checked 2026-09-08.

- **Package NDC:** 67457-421-30 _(verified: appears in the quote below)_
- **Generic name:** Dexamethasone Sodium Phosphate Injection _(verified: appears in the quote below)_
- **Manufacturer:** Mylan Institutional, a Viatris Company _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **Initial posting date:** 02/08/2019 _(verified: appears in the quote below)_
- **Last update date:** 08/20/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 2762 _(our reading, not quoted from the source)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Dermatology _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "02/08/2019", "package_ndc": "67457-421-30", "generic_name": "Dexamethasone Sodium Phosphate Injection", "contact_info": "800-796-9526", "availability": "Available"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/20/2026", "therapeutic_category": [ "Dermatology", "Endocrinology/Metabolism", "Gastroenterology", "Hematology", "Neurology", "Oncology", "Ophthalmology", "Other", "Pulmonary/Allergy", "Rheumatology" ], "dosage_form": "Injection", "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30)", "company_name": "Mylan Institutional, a Viatris Company", "status": "Current"

### Status

> "update_date": "08/20/2026", "therapeutic_category": [ "Dermatology", "Endocrinology/Metabolism", "Gastroenterology", "Hematology", "Neurology", "Oncology", "Ophthalmology", "Other", "Pulmonary/Allergy", "Rheumatology" ], "dosage_form": "Injection", "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30)", "company_name": "Mylan Institutional, a Viatris Company", "status": "Current"

### Last update date

> "update_date": "08/20/2026", "therapeutic_category": [ "Dermatology", "Endocrinology/Metabolism", "Gastroenterology", "Hematology", "Neurology", "Oncology", "Ophthalmology", "Other", "Pulmonary/Allergy", "Rheumatology" ], "dosage_form": "Injection", "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30)", "company_name": "Mylan Institutional, a Viatris Company", "status": "Current"

### Dosage form

> "update_date": "08/20/2026", "therapeutic_category": [ "Dermatology", "Endocrinology/Metabolism", "Gastroenterology", "Hematology", "Neurology", "Oncology", "Ophthalmology", "Other", "Pulmonary/Allergy", "Rheumatology" ], "dosage_form": "Injection", "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30)", "company_name": "Mylan Institutional, a Viatris Company", "status": "Current"

### Therapeutic category

> "update_date": "08/20/2026", "therapeutic_category": [ "Dermatology", "Endocrinology/Metabolism", "Gastroenterology", "Hematology", "Neurology", "Oncology", "Ophthalmology", "Other", "Pulmonary/Allergy", "Rheumatology" ], "dosage_form": "Injection", "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30)", "company_name": "Mylan Institutional, a Viatris Company", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-08. Review by: 2026-09-11.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).